We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Moderate Growth Expected for Global Medical Device Market

By HospiMedica International staff writers
Posted on 04 Jan 2015
Print article
While the global market for medical devices reached an estimated USD 361 billion in 2014, the average growth was only 3%. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

The growth was driven by countries outside of the traditional markets that include the United States, where the second year of collections on the medical device tax has begun, and in Europe, where reimbursement challenges and the threat of new legislation loom. Emerging markets, such as Brazil, Turkey, South Africa, Chile, Mexico, and others, which represent almost a fifth of the world device market, helped to boost revenues, although other emerging nations saw growth rate reductions.

As a result, more device companies are expected to focus on these import-heavy markets, find new markets, boost innovation and technology, and merge in order to remain competitive. In all markets, the report found, the key customers of medical devices are hospitals, and so to some degree they determine the success and development areas of the market. Catheters, orthopedic, dialysis, patient monitoring, ultrasound, X-Ray, medical beds, infusion pumps, stents, respiratory, point of care testing devices, and dental equipment are some of categories of medical devices that showed growth.

“It’s a challenging market with mild growth for standard products, but there are opportunities for companies that can innovate, and there’s been considerable amount of value placed on companies that are acquired.” said Bruce Carlson, Publisher of Kalorama Information. “Though most of revenue in the market is earned by eighteen [companies], there are hundreds of smaller companies that develop innovative single products or services.”

The eighteen companies that are the drivers of the global revenue in the device market include such conglomerates as Johnson & Johnson (New Brunswick, NJ, USA), GE Healthcare (GE; Little Chalfont, United Kingdom), Siemens (Munich, Germany), and Medtronic (Minneapolis, MN, USA).

Related Links:

Kalorama Information
Johnson & Johnson
GE Healthcare


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Display
i3 Series

Print article

Channels

Surgical Techniques

view channel
Image: Computational models can predict future structural integrity of a child’s heart valves (Photo courtesy of 123RF)

Computational Models Predict Heart Valve Leakage in Children

Hypoplastic left heart syndrome is a serious birth defect in which the left side of a baby’s heart is underdeveloped and ineffective at pumping blood, forcing the right side to handle the circulation to... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.